المؤلفون: Helsingen LM; Clinical Effectiveness Research Group, Institute of Health and Society, University of Oslo, Oslo, Norway. lisemhe@medisin.uio.no., Løberg M; Clinical Effectiveness Research Group, Institute of Health and Society, University of Oslo, Oslo, Norway., Bretthauer M; Clinical Effectiveness Research Group, Institute of Health and Society, University of Oslo, Oslo, Norway., Kalager M; Clinical Effectiveness Research Group, Institute of Health and Society, University of Oslo, Oslo, Norway.

المصدر: BMC public health [BMC Public Health] 2022 Dec 27; Vol. 22 (1), pp. 2437. Date of Electronic Publication: 2022 Dec 27.

نوع المنشور: Randomized Controlled Trial; Journal Article; Comment

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100968562 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2458 (Electronic) Linking ISSN: 14712458 NLM ISO Abbreviation: BMC Public Health Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19* , Fitness Centers*, Humans ; SARS-CoV-2 ; Norway/epidemiology ; COVID-19 Drug Treatment

المؤلفون: Akwiwu EU; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Epidemiology and Data Science, Amsterdam Public Health, Amsterdam, The Netherlands. e.akwiwu@amsterdamumc.nl., Klausch T; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Epidemiology and Data Science, Amsterdam Public Health, Amsterdam, The Netherlands., Jodal HC; Clinical Effectiveness Research Group, University of Oslo and Oslo University Hospital, Oslo, Norway., Carvalho B; Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Løberg M; Clinical Effectiveness Research Group, University of Oslo and Oslo University Hospital, Oslo, Norway., Kalager M; Clinical Effectiveness Research Group, University of Oslo and Oslo University Hospital, Oslo, Norway., Berkhof J; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Epidemiology and Data Science, Amsterdam Public Health, Amsterdam, The Netherlands., Coupé VMH; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Epidemiology and Data Science, Amsterdam Public Health, Amsterdam, The Netherlands.

المصدر: BMC medical research methodology [BMC Med Res Methodol] 2022 Jun 27; Vol. 22 (1), pp. 179. Date of Electronic Publication: 2022 Jun 27.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100968545 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2288 (Electronic) Linking ISSN: 14712288 NLM ISO Abbreviation: BMC Med Res Methodol Subsets: MEDLINE

مواضيع طبية MeSH: Adenoma*/diagnosis , Adenoma*/epidemiology , Colorectal Neoplasms*/diagnosis , Colorectal Neoplasms*/epidemiology, Colonoscopy ; Early Detection of Cancer/methods ; Humans ; Incidence ; Likelihood Functions

المؤلفون: Helsingen LM; Clinical Effectiveness Research Group, University of Oslo and Oslo University Hospital, Oslo, Norway. lisemhe@medisin.uio.no., Løberg M; Clinical Effectiveness Research Group, University of Oslo and Oslo University Hospital, Oslo, Norway., Refsum E; Clinical Effectiveness Research Group, University of Oslo and Oslo University Hospital, Oslo, Norway., Gjøstein DK; Clinical Effectiveness Research Group, University of Oslo and Oslo University Hospital, Oslo, Norway., Wieszczy P; Clinical Effectiveness Research Group, University of Oslo and Oslo University Hospital, Oslo, Norway., Olsvik Ø; Institute of Medical Biology, Norwegian Arctic University, Tromsø, Norway., Juul FE; Clinical Effectiveness Research Group, University of Oslo and Oslo University Hospital, Oslo, Norway., Barua I; Clinical Effectiveness Research Group, University of Oslo and Oslo University Hospital, Oslo, Norway., Jodal HC; Clinical Effectiveness Research Group, University of Oslo and Oslo University Hospital, Oslo, Norway., Herfindal M; Clinical Effectiveness Research Group, University of Oslo and Oslo University Hospital, Oslo, Norway., Mori Y; Clinical Effectiveness Research Group, University of Oslo and Oslo University Hospital, Oslo, Norway., Jore S; Norwegian Institute of Public Health, Oslo, Norway., Lund-Johansen F; Department of Immunology, Oslo University Hospital, Oslo, Norway., Fretheim A; Norwegian Institute of Public Health, Oslo, Norway., Bretthauer M; Clinical Effectiveness Research Group, University of Oslo and Oslo University Hospital, Oslo, Norway., Kalager M; Clinical Effectiveness Research Group, University of Oslo and Oslo University Hospital, Oslo, Norway.

مؤلفون مشاركون: TRAiN study group

المصدر: BMC public health [BMC Public Health] 2021 Nov 16; Vol. 21 (1), pp. 2103. Date of Electronic Publication: 2021 Nov 16.

نوع المنشور: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100968562 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2458 (Electronic) Linking ISSN: 14712458 NLM ISO Abbreviation: BMC Public Health Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19* , Fitness Centers*, Humans ; Pandemics ; RNA, Viral ; SARS-CoV-2 ; Treatment Outcome

المؤلفون: Helsingen LM; Clinical Effectiveness Research group, Institute for Health and Society, University of Oslo and Oslo University Hospital, PO Box 1089, Blindern, 0318, Oslo, Norway. lisemhe@medisin.uio.no., Refsum E; Clinical Effectiveness Research group, Institute for Health and Society, University of Oslo and Oslo University Hospital, PO Box 1089, Blindern, 0318, Oslo, Norway., Gjøstein DK; Clinical Effectiveness Research group, Institute for Health and Society, University of Oslo and Oslo University Hospital, PO Box 1089, Blindern, 0318, Oslo, Norway., Løberg M; Clinical Effectiveness Research group, Institute for Health and Society, University of Oslo and Oslo University Hospital, PO Box 1089, Blindern, 0318, Oslo, Norway., Bretthauer M; Clinical Effectiveness Research group, Institute for Health and Society, University of Oslo and Oslo University Hospital, PO Box 1089, Blindern, 0318, Oslo, Norway., Kalager M; Clinical Effectiveness Research group, Institute for Health and Society, University of Oslo and Oslo University Hospital, PO Box 1089, Blindern, 0318, Oslo, Norway., Emilsson L; Clinical Effectiveness Research group, Institute for Health and Society, University of Oslo and Oslo University Hospital, PO Box 1089, Blindern, 0318, Oslo, Norway.; Department of General Practice, Institute of Health and Society, University of Oslo, Oslo, Norway.; Vårdcentralen Årjäng and Centre for Clinical Research, County Council of Värmland, Värmland, Sweden.; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

مؤلفون مشاركون: Clinical Effectiveness Research group

المصدر: BMC public health [BMC Public Health] 2020 Oct 23; Vol. 20 (1), pp. 1597. Date of Electronic Publication: 2020 Oct 23.

نوع المنشور: Comparative Study; Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100968562 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2458 (Electronic) Linking ISSN: 14712458 NLM ISO Abbreviation: BMC Public Health Subsets: MEDLINE

مواضيع طبية MeSH: Life Style* , Trust*, Coronavirus Infections/*epidemiology , Coronavirus Infections/*prevention & control , Pandemics/*prevention & control , Pneumonia, Viral/*epidemiology , Pneumonia, Viral/*prevention & control, Adolescent ; Adult ; COVID-19 ; Female ; Humans ; Male ; Middle Aged ; Norway/epidemiology ; Risk Assessment ; Schools/organization & administration ; Surveys and Questionnaires ; Sweden/epidemiology ; Young Adult

المؤلفون: Seppälä TT; 1Department of Surgery, Helsinki University Central Hospital, P.O. Box 340, 00029 HUS Helsinki, Finland.; 2University of Helsinki, Helsinki, Finland., Ahadova A; 3Heidelberg University Hospital and DKFZ, Heidelberg, Germany., Dominguez-Valentin M; 4Department of Tumor Biology, Institute of Cancer Research, The Norwegian Radium Hospital, part of Oslo University Hospital, Olso, Norway.; 5Department of Medical Genetics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway., Macrae F; 6The Royal Melbourne Hospital, Melbourne, Australia.; 7University of Melbourne, Melbourne, Australia., Evans DG; 8University of Manchester & Manchester University Hospitals Foundation Trust, Manchester, UK., Therkildsen C; The Danish HNPCC Register, Clinical Research Centre, Copenhagen University Hospital, Hvidovre, Denmark., Sampson J; 10Medical Genetics, Cardiff University, Cardiff, UK., Scott R; University of Newcastle and the Hunter Medical Research Institute, Callaghan, Australia., Burn J; 12University of Newcastle, Newcastle upon Tyne, UK., Möslein G; 13University Witten-Herdecke, Wuppertal, Germany., Bernstein I; 14Dept. of Surgical Gastroenterology, Aalborg University Hospital, Aalborg, Denmark., Holinski-Feder E; 15Medizinische Klinik und Poliklinik IV, Campus Innenstadt, Klinikum der Universität München, Munich, Germany.; 16MGZ- Medical Genetics Center, Munich, Germany., Pylvänäinen K; 17Central Finland Central Hospital, Education and Research, Jyväskylä, Finland., Renkonen-Sinisalo L; 1Department of Surgery, Helsinki University Central Hospital, P.O. Box 340, 00029 HUS Helsinki, Finland., Lepistö A; 1Department of Surgery, Helsinki University Central Hospital, P.O. Box 340, 00029 HUS Helsinki, Finland., Lautrup CK; 18Department of Clinical Genetics, Aalborg University Hospital, Aalborg, Denmark., Lindblom A; 19Karolinska Institutet, Stockholm, Sweden., Plazzer JP; 6The Royal Melbourne Hospital, Melbourne, Australia., Winship I; 6The Royal Melbourne Hospital, Melbourne, Australia.; 7University of Melbourne, Melbourne, Australia., Tjandra D; 6The Royal Melbourne Hospital, Melbourne, Australia., Katz LH; 20Hadassah Medical Center, Jerusalem, and Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel., Aretz S; 21Institute of Human Genetics, University of Bonn, Bonn, Germany., Hüneburg R; 22Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany.; 23Center for Hereditary Tumor Syndromes, University Hospital Bonn, Bonn, Germany., Holzapfel S; 22Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany.; 23Center for Hereditary Tumor Syndromes, University Hospital Bonn, Bonn, Germany., Heinimann K; 24Institute for Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland., Valle AD; Hospital Fuerzas Armadas, Grupo Colaborativo Uruguayo, Investigación de Afecciones Oncológicas Hereditarias (GCU), Montevideo, Uruguay., Neffa F; Hospital Fuerzas Armadas, Grupo Colaborativo Uruguayo, Investigación de Afecciones Oncológicas Hereditarias (GCU), Montevideo, Uruguay., Gluck N; Tel-Aviv Soursky Medical Center, Tel-Aviv, Israel., de Vos Tot Nederveen Cappel WH; 27Department of Gastroenterology and Hepatology, Isala Clinics, Zwolle, The Netherlands., Vasen H; 28Department of Gastroenterology and Hepatology, Leiden University Medical Centre, Leiden, The Netherlands., Morak M; 15Medizinische Klinik und Poliklinik IV, Campus Innenstadt, Klinikum der Universität München, Munich, Germany.; 16MGZ- Medical Genetics Center, Munich, Germany., Steinke-Lange V; 15Medizinische Klinik und Poliklinik IV, Campus Innenstadt, Klinikum der Universität München, Munich, Germany.; 16MGZ- Medical Genetics Center, Munich, Germany., Engel C; 29Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany., Rahner N; 30Medical School, Institute of Human Genetics, Heinrich-Heine-University, Düsseldorf, Germany., Schmiegel W; 31Department of Medicine, Knappschaftskrankenhaus, Ruhr-University Bochum, Bochum, Germany., Vangala D; 31Department of Medicine, Knappschaftskrankenhaus, Ruhr-University Bochum, Bochum, Germany., Thomas H; 32St Mark's Hospital, Department of Surgery and Cancer, Imperial College London, London, UK., Green K; 8University of Manchester & Manchester University Hospitals Foundation Trust, Manchester, UK., Lalloo F; 8University of Manchester & Manchester University Hospitals Foundation Trust, Manchester, UK., Crosbie EJ; 33University of Manchester and St Mary's Hospital, Manchester, UK., Hill J; 8University of Manchester & Manchester University Hospitals Foundation Trust, Manchester, UK., Capella G; Hereditary Cancer Program, Catalan Institute of Oncology, Insititut d'Investigació Biomèdica de Bellvitge (IDIBELL), ONCOBELL Program, L'Hospitalet de Llobregat, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain., Pineda M; Hereditary Cancer Program, Catalan Institute of Oncology, Insititut d'Investigació Biomèdica de Bellvitge (IDIBELL), ONCOBELL Program, L'Hospitalet de Llobregat, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain., Navarro M; Hereditary Cancer Program, Catalan Institute of Oncology, Insititut d'Investigació Biomèdica de Bellvitge (IDIBELL), ONCOBELL Program, L'Hospitalet de Llobregat, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain., Blanco I; Hereditary Cancer Program, Catalan Institute of Oncology, Insititut d'Investigació Biomèdica de Bellvitge (IDIBELL), ONCOBELL Program, L'Hospitalet de Llobregat, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain., Ten Broeke S; 36University Medical Center Groningen, Groningen, the Netherlands., Nielsen M; 37Leids Universitair Medisch Centrum, Leiden, Netherlands., Ljungmann K; 38Department of Surgical Gastroenterology, Aarhus University Hospital, Aarhus, Denmark., Nakken S; 4Department of Tumor Biology, Institute of Cancer Research, The Norwegian Radium Hospital, part of Oslo University Hospital, Olso, Norway., Lindor N; 39Department of Health Sciences Research, Mayo Clinic, Scottsdale, AZ USA., Frayling I; 10Medical Genetics, Cardiff University, Cardiff, UK., Hovig E; 4Department of Tumor Biology, Institute of Cancer Research, The Norwegian Radium Hospital, part of Oslo University Hospital, Olso, Norway.; 40Center for Bioinformatics, Department of Informatics, University of Oslo, Oslo, Norway., Sunde L; 41Department of Medical Genetics, Aarhus University Hospital, Aarhus, Denmark., Kloor M; 3Heidelberg University Hospital and DKFZ, Heidelberg, Germany., Mecklin JP; 42Department of Surgery, Central Finland Central Hospital, Jyväskylä, Finland.; 43Faculty of Sport and Health Sciences, University of Jyväskylä, Jyväskylä, Finland., Kalager M; 4Department of Tumor Biology, Institute of Cancer Research, The Norwegian Radium Hospital, part of Oslo University Hospital, Olso, Norway.; 44University of Oslo, Oslo, Norway.; 45Harvard School of Public Health, Boston, MA USA., Møller P; 4Department of Tumor Biology, Institute of Cancer Research, The Norwegian Radium Hospital, part of Oslo University Hospital, Olso, Norway.; 13University Witten-Herdecke, Wuppertal, Germany.; 5Department of Medical Genetics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.

المصدر: Hereditary cancer in clinical practice [Hered Cancer Clin Pract] 2019 Feb 28; Vol. 17, pp. 8. Date of Electronic Publication: 2019 Feb 28 (Print Publication: 2019).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: Poland NLM ID: 101231179 Publication Model: eCollection Cited Medium: Print ISSN: 1731-2302 (Print) Linking ISSN: 17312302 NLM ISO Abbreviation: Hered Cancer Clin Pract Subsets: PubMed not MEDLINE

المؤلفون: Swanson SA; Department of Epidemiology, Erasmus Medical Center, PO Box 2040, 3000, CA, Rotterdam, The Netherlands. sswanson@hsph.harvard.edu.; Department of Epidemiology, Harvard TH Chan School of Public Health, Boston, MA, USA. sswanson@hsph.harvard.edu., Holme Ø; Institute of Health and Society, University of Oslo, Oslo, Norway. oyvind.holme@medisin.uio.no.; Sørlandet Hospital Kristiansand, Kristiansand, Norway. oyvind.holme@medisin.uio.no., Løberg M; Institute of Health and Society, University of Oslo, Oslo, Norway. magnus.loberg@medisin.uio.no.; Oslo University Hospital, Oslo, Norway. magnus.loberg@medisin.uio.no., Kalager M; Department of Epidemiology, Harvard TH Chan School of Public Health, Boston, MA, USA. mkalager@hsph.harvard.edu.; Institute of Health and Society, University of Oslo, Oslo, Norway. mkalager@hsph.harvard.edu.; Telemark Hospital, Skien, Norway. mkalager@hsph.harvard.edu., Bretthauer M; Department of Epidemiology, Harvard TH Chan School of Public Health, Boston, MA, USA. michael.bretthauer@medisin.uio.no.; Institute of Health and Society, University of Oslo, Oslo, Norway. michael.bretthauer@medisin.uio.no.; Oslo University Hospital, Oslo, Norway. michael.bretthauer@medisin.uio.no., Hoff G; Institute of Health and Society, University of Oslo, Oslo, Norway. Geir.Hoff@kreftregisteret.no.; Telemark Hospital, Skien, Norway. Geir.Hoff@kreftregisteret.no.; Cancer Registry of Norway, Oslo, Norway. Geir.Hoff@kreftregisteret.no., Aas E; Institute of Health and Society, University of Oslo, Oslo, Norway. eline.aas@medisin.uio.no., Hernán MA; Department of Epidemiology, Harvard TH Chan School of Public Health, Boston, MA, USA. miguel_hernan@post.harvard.edu.; Department of Biostatistics, Harvard TH Chan School of Public Health, Boston, MA, USA. miguel_hernan@post.harvard.edu.; Harvard-MIT Division of Health Sciences and Technology, Boston, MA, USA. miguel_hernan@post.harvard.edu.

المصدر: Trials [Trials] 2015 Nov 30; Vol. 16, pp. 541. Date of Electronic Publication: 2015 Nov 30.

نوع المنشور: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215 (Electronic) Linking ISSN: 17456215 NLM ISO Abbreviation: Trials Subsets: MEDLINE

مواضيع طبية MeSH: Sigmoidoscopy*/statistics & numerical data, Colorectal Neoplasms/*pathology , Early Detection of Cancer/*methods, Clinical Protocols ; Colorectal Neoplasms/mortality ; Data Interpretation, Statistical ; Early Detection of Cancer/statistics & numerical data ; Female ; Humans ; Male ; Middle Aged ; Norway ; Patient Selection ; Predictive Value of Tests ; Prognosis ; Research Design ; Risk Assessment ; Risk Factors ; Time Factors